EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity

Journal of Immunology

Volumn 177, Issue 5, 2006, Pages 2793-2802

  Wang, Hongsheng ^a,b   Nicholas, Matilda W ^a   Conway, Kara L ^a   Sen, Pradip ^a   Diz, Ramiro ^a   Tisch, Roland M ^a   Clarke, Stephen H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN; LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; PROTEIN SM; RIBONUCLEOPROTEIN; SM ANTIBODY; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HYPERSENSITIVITY; IMMUNE SYSTEM; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSGENE; TRANSGENIC MOUSE;

EID: 33747794039     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.5.2793     Document Type: Article

References (64)

1. Evans, A. S., N. F. Rothfield, and J. C. Niederman. 1971. Raised antibody titres to EB virus in systemic lupus erythematosus. Lancet 1: 167-168.
2. Yokochi, T., A. Yanagawa, Y. Kimura, and Y. Mizushima. 1989. High titer of antibody to the Epstein-Barr viras membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus. J. Rheumatol. 16: 1029-1032.
3. Kitagawa, H., S. Iho, T. Yokochi, and T. Hoshino. 1988. Detection of antibodies to the Epstein-Barr viras nuclear antigens in the sera from patients with systemic lupus erythematosus. lmmunol. Lett. 17: 249-252.
4. Verdolini, R., L. Bugatti, M. Giangiacomi, M. Nicolini, G. Filosa, and R. Cerio. 2002. Systemic lupus erythematosus induced by Epstein-Barr virus infection. Br. J. Dermatol. 146: 877-881.
5. James, J. A., K. M. Kaufman, A. D. Farris, E. Taylor-Albert, T. J. Lehman, and J. B. Harley. 1997. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J. Clin. Invest. 100: 3019-3026.
6. James, J. A., B. R. Neas, K. L. Moser, T. Hall, G. R. Bruner, A. L. Sestak, and J. B. Harley. 2001. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 44: 1122-1126.
7. Dror, Y., Y. Blachar, P. Cohen, N. Livni, E. Rosenmann, and A. Ashkenazi. 1998. Systemic lupus erythematosus associated with acute Epstein-Barr virus infection. Am. J. Kidney Dis. 32: 825-828.
8. Huggins, M. L., I. Todd, and R. J. Powell. 2005. Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus. Rheumatol. Int. 25: 183-187.
9. Kang, I., T. Quan, H. Nolasco, S. H. Park, M. S. Hong, J. Crouch, E. G. Pamer, J. G. Howe, and J. Craft. 2004. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J. Immunol. 172: 1287-1294.
10. Gross, A. J., D. Hochberg, W. M. Rand, and D. A. Thorley-Lawson. 2005. EBV and systemic lupus erythematosus: a new perspective. J. Immunol. 174: 6599-6607.
11. Garzelli, C., F. E. Taub, J. E. Scharff, B. S. Prabhakar, F. Ginsberg-Fellner, and A. L. Notkins. 1984. Epstein-Barr virus-transformed lymphocytes produce monoclonal autoantibodies that react with antigens in multiple organs. J. Virol. 52: 722-725.
12. Rhodes, G., H. Rumpold, P. Kurki, K. M. Patrick, D. A. Carson, and J. H. Vaughan. 1987. Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen. J. Exp. Med. 165: 1026-1040.
13. Vaughan, J. H., M. D. Nguyen, J. R. Valbracht, K. Patrick, G. H. Rhodes, H. H. Handley, and R. S. Smith. 1995. Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes: presence in autoimmune disease. J. Clin. Invest. 95: 1316-1327.
14. Vaughan, J. H., J. R. Valbracht, M. D. Nguyen, H. H. Handley, R. S. Smith, K. Patrick, and G. H. Rhodes. 1995. Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1. J. Clin. Invest. 95: 1306-1315.
15. Sabbatini, A., S. Bombardieri, and P. Migliorini. 1993. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur. J. Immunol. 23: 1146-1152.
16. McClain, M. T., L. D. Heinlen, G. J. Dennis, J. Roebuck, J. B. Harley, and J. A. James. 2005. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat. Med. 11: 85-89.
17. Sundar, K., S. Jacques, P. Gottlieb, R. Villars, M. E. Benito, D. K. Taylor, and L. A. Spatz. 2004. Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J. Autoimmun. 23: 127-140.
18. James, J. A., R. H. Scofield, and J. B. Harley. 1997. Lupus humoral autoimmunity after short peptide immunization. Ann. NY Acad. Sci. 815: 124-127.
19. Portis, T., and R. Longnecker. 2004. Epstein-Barr viras (EBV) LMP2A mediates B lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Oncogene 23: 8619-8628.
20. Miller, C. L., R. Longnecker, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J. Virol. 67: 3087-3094.
21. Miller, C. L., A. L. Burkhardt, J. H. Lee, B. Stealey, R. Longnecker, J. B. Bolen, and E. Kieff. 1995. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2: 155-166.
22. Caldwell, R. G., J. B. Wilson, S. J. Anderson, and R. Longnecker. 1998. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9: 405-411.
23. Swanson-Mungerson, M. A., R. G. Caldwell, R. Bultema, and R. Longnecker. 2005. Epstein-Barr viras LMP2A alters in vivo and in vitro models of B cell anergy, but not deletion, in response to autoantigen. J. Virol. 79: 7355-7362.
24. Santulli-Marotto, S., M, W. Retter, R. Gee, M. J. Mamula, and S. H. Clarke. 1998. Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity 8: 209-219.
25. Borrero, M., and S. H. Clarke. 2002. Low-affinity anti-Smith antigen B cells are regulated by anergy as opposed to developmental arrest or differentiation to B-1. J. Immunol. 168: 13-21.
26. Culton, D. A., P. O'Conner, B., K. L. Conway, R. Diz, J. Rutan, B. J. Vilen, and S. H. Clarke. 2006. Early preplasma cells define a tolerance checkpoint for autoreactive B cells. J. Immunol. 176: 790-802.
27. Shapiro-Shelef, M., K. I. Lin, L. J. McHeyzer-Williams, J. Liao, M. G. McHeyzer-Williams, and K. Calame. 2003. Blimp-1 is required for the formation of Immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 19: 607-620.
28. + B cells. J. Immunol. 167: 1254-1262.
29. Irish, J. M., R. Hovland, P. O. Krutzik, O. D. Perez, O. Bruserud, B. T. Gjertsen, and G. P. Nolan. 2004. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118: 217-228.
30. Qian, Y., H. Wang, and S. H. Clarke. 2004. Impaired clearance of apoptotic cells induces the activation of autoreactive anti-Sm marginal zone and B-1 B cells. J. Immunol. 172: 625-635.
31. Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I κBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13: 3301-3310.
32. Sen, P., S. Bhattacharyya, M. Wallet, C. P. Wong, B. Poligone, M. Sen, A. S. Baldwin, Jr., and R. Tisch. 2003. NF-κB hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages. J. Immunol. 170: 1770-1780.
33. Qian, Y., C. Santiago, M. Borrero, T. F. Tedder, and S. H. Clarke. 2001. Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds. J. Immunol. 166: 2412-2419.
34. + B-1 cell development. J. Immunol. 172: 5329-5337.
35. Arnold, L. W., S. K. McCray, C. Tatu, and S. H. Clarke. 2000. Identification of a precursor to phosphatidyl choline-specific B-1 cells suggesting that B-1 cells differentiate from splenic conventional B cells in vivo: cyclosporin A blocks differentiation to B-1. J. Immunol. 164: 2924-2930.
36. Miller, C. L., J. H. Lee, E. Kieff, and R. Longnecker. 1994. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc. Natl. Acad. Sci. USA 91: 772-776.
37. Healy, J. I., R. E. Dolmetsch, L. A. Timmerman, J. G. Cyster, M. L. Thomas, G. R. Crabtree, R. S. Lewis, and C. C. Goodnow. 1997. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 6: 419-428.
38. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607.
39. Viglianti, G. A., C. M. Lau, T. M. Hanley, B. A. Miko, M. J. Shlomchik, and A. Marshak-Rothstein. 2003. Activation of autoreactive B cells by CpG dsDNA. Immunity 19: 837-847.
40. Moser, K., G. Muehlinghaus, R. Manz, H. Mei, C. Voigt, T. Yoshida, T. Dorner, F. Hiepe, and A. Radbruch. 2005. Long-lived plasma cells in immunity and immunopathology. Immunol. Lett. 103: 83-85.
41. Christensen, S. R., M. Kashgarian, L. Alexopoulou, R. A. Flavell, S. Akira, and M. J. Shlomchik. 2005. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202: 321-331.
42. Scholle, F., K. M. Bendt, and N. Raab-Traub. 2000. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J. Virol. 74: 10681-10689.
43. Fukuda, M., and R. Longnecker. 2004. Latent membrane protein 2A inhibits transforming growth factor β1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway. J. Virol. 78: 1697-1705.
44. Francois, S., J. El Benna, P. M. Dang, E. Pedruzzi, M. A. Gougerot-Pocidalo, and C. Elbim. 2005. Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-κB signaling pathways, leading to increased levels of Mc1-1, Al, and phosphorylated Bad. J. Immunol. 174: 3633-3642.
45. Ojaniemi, M., V. Glumoff, K. Harju, M. Liljeroos, K. Vuori, and M. Hallman. 2003. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur. J. Immunol. 33: 597-605.
46. Zarember, K. A., and P. J. Godowski. 2002. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168: 554-561.
47. Miyashita, E. M., B. Yang, K. M. Lam, D. H. Crawford, and D. A. Thorley-Lawson. 1995. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80: 593-601.
48. Wagner, M., H. Poeck, B. Jahrsdoerfer, S. Rothenfusser, D. Prell, B. Bohle, E. Tuma, T. Giese, J. W. Ellwart, S. Endres, and G. Hartmann. 2004. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J. Immunol. 172: 954-963.
49. Wen, S., N. Shimizu, H. Yoshiyama, Y. Mizugaki, F. Shinozaki, and K. Takada. 1996. Association of Epstein-Barr virus (EBV) with Sjogren's syndrome: differential EBV expression between epithelial cells and lymphocytes in salivary glands. Am. J. Pathol. 149: 1511-1517.
50. Scotet, E., J. David-Ameline, M. A. Peyrat, A. Moreau-Aubry, D. Pinczon, A. Lim, J. Even, G. Semana, J. M. Berthelot, R. Breathnach, et al. 1996. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J. Exp. Med. 184: 1791-1800.
51. Ascherio, A., and M. Munch. 2000. Epstein-Barr virus and multiple sclerosis. Epidemiology 11: 220-224.
52. Vento, S., L. Guella, F. Mirandola, F. Cainelli, G. Di Perri, M. Solbiati, T. Ferraro, and E. Concia. 1995. Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet 346: 608-609.
53. Thorley-Lawson, D. A., and G. I. Babcock. 1999. A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells. Life Sci. 65: 1433-1453.
54. Busch, L. K., and G. A. Bishop. 1999. The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes. J. Immunol. 162: 2555-2561.
55. Bernasconi, N. L., N. Onai, and A. Lanzavecchia. 2003. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101: 4500-4504.
56. Bemasconi, N. L., E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298: 2199-2202.
57. Nath, S. K., J. Kilpatrick, and J. B. Harley. 2004. Genetics of human systemic lupus erythematosus: the emerging picture. Curr. Opin. Immunol. 16: 794-800.
58. Wakeland, E. K., K. Liu, R. R. Graham, and T. W. Behrens. 2001. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15: 397-408.
59. Santulli-Marotto, S., Y. Qian, S. Ferguson, and S. H. Clarice. 2001. Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: altered differentiation and an accelerated response. J. Immunol. 166: 5292-5299.
60. Yurasov, S., H. Wardemann, J. Hammersen, M. Tsuiji, E. Meffre, V. Pascual, and M. C. Nussenzweig. 2005. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201: 703-711.
61. William, J., C. Euler, S. Christensen, and M. J. Shlomchik. 2002. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297: 2066-2070.
62. Laichalk, L. L., and D. A. Thorley-Lawson. 2005. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79: 1296-1307.
63. Gordon, T., F. Topfer, C. Keech, P. Reynolds, W. Chen, M. Rischmueller, and I. McCluskey. 1994. How does autoimmunity to La and Ro initiate and spread? Autoimmunity 18: 87-92.
64. Poole, B. D., R. H. Scofield, J. B. Harley, and J. A. James. 2006. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 39: 63-70.